MARKET

DCTH

DCTH

Delcath Sys
NASDAQ
9.55
+0.43
+4.70%
Opening 12:09 02/13 EST
OPEN
9.22
PREV CLOSE
9.12
HIGH
9.55
LOW
9.20
VOLUME
99.56K
TURNOVER
--
52 WEEK HIGH
18.23
52 WEEK LOW
8.12
MARKET CAP
331.33M
P/E (TTM)
1097.52
1D
5D
1M
3M
1Y
5Y
1D
Delcath Systems Inc. announces upcoming earnings call
Reuters · 1d ago
Press Release: Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call
Dow Jones · 1d ago
Weekly Report: what happened at DCTH last week (0202-0206)?
Weekly Report · 4d ago
Weekly Report: what happened at DCTH last week (0126-0130)?
Weekly Report · 02/02 09:15
Weekly Report: what happened at DCTH last week (0119-0123)?
Weekly Report · 01/26 09:16
Delcath Systems Grants Equity Awards to New Employees Under Inducement Plan
Reuters · 01/21 21:01
DELCATH SYSTEMS, INC. ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 01/21 21:01
Weekly Report: what happened at DCTH last week (0112-0116)?
Weekly Report · 01/19 09:17
More
About DCTH
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's proprietary products, HEPZATO KIT (HEPZATO (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan percutaneous hepatic perfusion (PHP), are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects during a PHP procedure. HEPZATOTM KIT is a drug/device combination product. HEPZATO KIT is comprised of the chemotherapeutic drug melphalan and the Company’s proprietary Hepatic Delivery System (HDS). In Europe, the device-only configuration of the HDS is regulated as a Class III medical device and is approved for sale under the trade name CHEMOSAT Hepatic Delivery System for Melphalan. In the United States, HEPZATO is regulated as a drug by the United States Food and Drug Administration (FDA).

Webull offers Delcath Systems Inc stock information, including NASDAQ: DCTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DCTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DCTH stock methods without spending real money on the virtual paper trading platform.